{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:08:42Z","timestamp":1790190522033,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69662-3","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:02:12Z","timestamp":1723489332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A new animal model of cardiorenal syndrome could be established by inducing heart failure through coronary artery ligation in spontaneously hypertensive rats"],"prefix":"10.1038","volume":"14","author":[{"given":"Biye","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"69662_CR1","volume":"2012","author":"S Yagi","year":"2012","unstructured":"Yagi, S. et al. Effects of statins on cardiorenal syndrome. Int. J. Vasc. Med. 2012, 162545 (2012).","journal-title":"Int. J. Vasc. Med."},{"key":"69662_CR2","doi-asserted-by":"publisher","first-page":"F666","DOI":"10.1152\/ajprenal.00201.2022","volume":"323","author":"JH Dasinger","year":"2022","unstructured":"Dasinger, J. H. et al. Impact of bedding on Dahl salt-sensitive hypertension and renal damage. Am. J. Physiol. Ren. Physiol. 323, F666\u2013F672 (2022).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"69662_CR3","first-page":"997","volume":"17","author":"Y Naito","year":"2006","unstructured":"Naito, Y. et al. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int. J. Mol. Med. 17, 997\u20131004 (2006).","journal-title":"Int. J. Mol. Med."},{"key":"69662_CR4","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","volume":"47","author":"Y Ishikawa","year":"2006","unstructured":"Ishikawa, Y. et al. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 47, 1075\u20131083 (2006).","journal-title":"Hypertension"},{"key":"69662_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13662","volume":"232","author":"JM Abais-Battad","year":"2021","unstructured":"Abais-Battad, J. M. et al. Dietary influences on the Dahl SS rat gut microbiota and its effects on salt-sensitive hypertension and renal damage. Acta Physiologica 232, e13662 (2021).","journal-title":"Acta Physiologica"},{"key":"69662_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1586\/14779072.1.4.495","volume":"1","author":"RS Rosenson","year":"2003","unstructured":"Rosenson, R. S. Rosuvastatin: A new inhibitor of HMG-coA reductase for the treatment of dyslipidemia. Expert Rev. Cardiovasc. Ther. 1, 495\u2013505 (2003).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"69662_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2515\/therapie:2003016","volume":"58","author":"P Bousquet","year":"2003","unstructured":"Bousquet, P. & Gayet, J. L. Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor. Therapie 58, 113\u2013121 (2003).","journal-title":"Therapie"},{"key":"69662_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1527-3466.2002.tb00099.x","volume":"20","author":"AG Olsson","year":"2002","unstructured":"Olsson, A. G., McTaggart, F. & Raza, A. Rosuvastatin: A highly effective new HMG-CoA reductase inhibitor. Cardiovasc. Drug Rev. 20, 303\u2013328 (2002).","journal-title":"Cardiovasc. Drug Rev."},{"key":"69662_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00005344-200304000-00019","volume":"41","author":"Y Ikeda","year":"2003","unstructured":"Ikeda, Y., Young, L. H. & Lefer, A. M. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats. J. Cardiovasc. Pharmacol. 41, 649\u2013656 (2003).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"69662_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/01.HDX.0000050417.89309.F8","volume":"5","author":"A Cheng-Lai","year":"2003","unstructured":"Cheng-Lai, A. Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia. Heart Disease 5, 72\u201378 (2003).","journal-title":"Heart Disease"},{"key":"69662_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3949\/ccjm.85a.17019","volume":"85","author":"GS Thind","year":"2018","unstructured":"Thind, G. S., Loehrke, M. & Wilt, J. L. Acute cardiorenal syndrome: Mechanisms and clinical implications. Cleve Clin. J. Med. 85, 231\u2013239 (2018).","journal-title":"Cleve Clin. J. Med."},{"key":"69662_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","volume":"25","author":"B Giam","year":"2016","unstructured":"Giam, B., Kaye, D. M. & Rajapakse, N. W. Role of renal oxidative stress in the pathogenesis of the cardiorenal syndrome. Heart Lung Circ. 25, 874\u2013880 (2016).","journal-title":"Heart Lung Circ."},{"key":"69662_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/EC9.0000000000000049","volume":"2","author":"B Zhou","year":"2022","unstructured":"Zhou, B., Ao, Q., Zhao, H. & Ye, P. Rosuvastatin alleviates renal injury in cardiorenal syndrome model rats through anti-inflammatory and antioxidant pathways. Emerg. Crit. Care Med. 2, 203\u2013208 (2022).","journal-title":"Emerg. Crit. Care Med."},{"key":"69662_CR14","doi-asserted-by":"publisher","DOI":"10.3791\/52206-v","author":"I Muthuramu","year":"2014","unstructured":"Muthuramu, I., Lox, M., Jacobs, F. & De Geest, B. Permanent ligation of the left anterior descending coronary artery in mice: A model of postmyocardial infarction remodelling and heart failure. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52206-v (2014).","journal-title":"J. Vis. Exp."},{"key":"69662_CR15","doi-asserted-by":"publisher","DOI":"10.3791\/2464-v","author":"Y Wu","year":"2011","unstructured":"Wu, Y., Yin, X., Wijaya, C., Huang, M. H. & McConnell, B. K. Acute myocardial infarction in rats. J. Vis. Exp. https:\/\/doi.org\/10.3791\/2464-v (2011).","journal-title":"J. Vis. Exp."},{"key":"69662_CR16","doi-asserted-by":"publisher","first-page":"10470","DOI":"10.3390\/ijms241310470","volume":"24","author":"K Romejko","year":"2023","unstructured":"Romejko, K., Markowska, M. & Niemczyk, S. The review of current knowledge on neutrophil gelatinase-associated lipocalin (NGAL). Int. J. Mol. Sci. 24, 10470 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"69662_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108840","volume":"109","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Interleukin-22 exacerbates angiotensin II-induced hypertensive renal injury. Int. Immunopharmacol. 109, 108840 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"69662_CR18","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10741-022-10218-w","volume":"27","author":"CVC Junho","year":"2022","unstructured":"Junho, C. V. C. et al. Cardiorenal syndrome: Long road between kidney and heart. Heart Fail Rev. 27, 2137\u20132153 (2022).","journal-title":"Heart Fail Rev."},{"key":"69662_CR19","doi-asserted-by":"publisher","first-page":"F1253","DOI":"10.1152\/ajprenal.00392.2012","volume":"303","author":"LG Bongartz","year":"2012","unstructured":"Bongartz, L. G. et al. Target organ cross talk in cardiorenal syndrome: Animal models. Am. J. Physiol. Ren. Physiol. 303, F1253\u2013F1263 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"69662_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10741-011-9279-6","volume":"17","author":"MK Szymanski","year":"2012","unstructured":"Szymanski, M. K., de Boer, R. A., Navis, G. J., van Gilst, W. H. & Hillege, H. L. Animal models of cardiorenal syndrome: A review. Heart Fail Rev. 17, 411\u2013420 (2012).","journal-title":"Heart Fail Rev."},{"key":"69662_CR21","doi-asserted-by":"publisher","first-page":"F974","DOI":"10.1152\/ajprenal.00624.2017","volume":"316","author":"S Liu","year":"2019","unstructured":"Liu, S. Heart-kidney interactions: Mechanistic insights from animal models. Am. J. Physiol. Ren. Physiol. 316, F974\u2013F985 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"69662_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31083\/j.rcm2303111","volume":"23","author":"R Scagliola","year":"2022","unstructured":"Scagliola, R. & Brunelli, C. Venous congestion and systemic hypoperfusion in cardiorenal syndrome: Two sides of the same coin. Rev. Cardiovasc. Med. 23, 111 (2022).","journal-title":"Rev. Cardiovasc. Med."},{"key":"69662_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000447542","volume":"7","author":"J Zhang","year":"2016","unstructured":"Zhang, J., Fallahzadeh, M. K. & McCullough, P. A. Aging male spontaneously hypertensive rat as an animal model for the evaluation of the interplay between contrast-induced acute kidney injury and cardiorenal syndrome in humans. Cardiorenal Med. 7, 1\u201310 (2016).","journal-title":"Cardiorenal Med."},{"key":"69662_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.kint.2021.11.023","volume":"101","author":"JA Navarro-Garcia","year":"2022","unstructured":"Navarro-Garcia, J. A. & Ruiz-Hurtado, G. Murine models of uremic cardiomyopathy as a necessary tool to unravel mechanisms involved in cardiorenal syndrome. Kidney Int. 101, 214\u2013216 (2022).","journal-title":"Kidney Int."},{"key":"69662_CR25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/biom11091370","volume":"11","author":"S Liao","year":"2021","unstructured":"Liao, S. et al. Establishment of a drug screening model for cardiac complications of acute renal failure. Biomolecules 11, 1370 (2021).","journal-title":"Biomolecules"},{"key":"69662_CR26","first-page":"383","volume":"45","author":"YH Yang","year":"2020","unstructured":"Yang, Y. H. et al. Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics. Zhongguo Zhong Yao Za Zhi 45, 383\u2013390 (2020).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"69662_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.kint.2018.11.021","volume":"95","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. Wnt\/beta-catenin signalling mediates both heart and kidney injury in type 2 cardiorenal syndrome. Kidney Int. 95, 815\u2013829 (2019).","journal-title":"Kidney Int."},{"key":"69662_CR28","first-page":"325","volume":"70","author":"I Balint","year":"2016","unstructured":"Balint, I., Vucak, J., Basic-Markovic, N., Klaric, D. & Sakic, V. A. Pathophysiology of the cardiorenal syndrome. Acta Med. Croatica 70, 325\u2013331 (2016).","journal-title":"Acta Med. Croatica"},{"key":"69662_CR29","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00330-014-3571-5","volume":"25","author":"T Breidthardt","year":"2015","unstructured":"Breidthardt, T. et al. The pathophysiology of the chronic cardiorenal syndrome: A magnetic resonance imaging study. Eur. Radiol. 25, 1684\u20131691 (2015).","journal-title":"Eur. Radiol."},{"key":"69662_CR30","first-page":"1314","volume":"22","author":"G Mercanoglu","year":"2019","unstructured":"Mercanoglu, G. & Semen, O. Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome. Iran. J. Basic Med. Sci. 22, 1314\u20131324 (2019).","journal-title":"Iran. J. Basic Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69662-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69662-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69662-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T23:06:42Z","timestamp":1723763202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69662-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69662"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69662-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18732"}}